DGCA extends restrictions on domestic flights, fares capped till Nov 24

Govt notifies new e-commerce rules; mandatory to declare country of origin, expiry date

The Government has notified new rules for e-commerce companies, including mandatory display of 'country of origin' on their products, and said any non-compliance will attract penal action. The 'Consumer Protection (E-Commerce) Rules, 2020' were notified on Thursday. The new rules will be applicable to all electronic retailers (e-tailers) registered in India or abroad but offering goods and services to Indian consumers.

20% of routine legal work to be taken over by AI, blockchain

The legal profession, like many other sectors, will see disruptive change with 20 per cent of the routine legal works likely to be automated in the future, predicts a survey conducted by BML Munjal University (BMU). As many as 42 per cent of those surveyed believe that 20 per cent of the routine works like contract drafting and due diligence, etc will be taken over by technologies like artificial intelligence and blockchain.

Reliance Industries' Rs 11k crore day-trade historic peak for any firm on NSE

Mukesh Ambani-led Reliance Industries Ltd (RIL) recorded the highest value of transactions for a share ever on NSE yesterday in a session during which the large cap stock rose to a fresh all-time high. RIL recorded share transactions worth Rs 11,846.65 crore after 5.56 crore shares changed hands on NSE on July 24.

Lockdown: DGCA extends restrictions on domestic flights, fare capping till Nov 24

Aviation regulator DGCA on Friday extended restrictions on domestic flights till November 24, 2020 in wake of the coronavirus pandemic. The regulator also extended the fare cap on domestic flights until November 24, 2020, or until further orders. In May, the civil aviation ministry had put a cap on upper and lower limits on domestic airfares in order to prevent any sudden spike or fall in ticket prices during the period of COVID-19 pandemic.

Cipla to launch Favipiravir drug for coronavirus treatment at Rs 68 per tabletCipla on Friday said it has received the Drug Controller General of India (DCGI) approval for the launch of experimental coronavirus drug Favipiravir in India for treatment of COVID-19 patients. The drug, which is used to treat mild to moderate COVID-19 patients, will be commercially launched under the brand name Ciplenza in the first week of August priced at Rs 68 per tablet.

Coffee Day owner suicide: Siddhartha's personal business owes Group over Rs 3,500 crore

The investigation by Coffee Day Enterprises (CDEL) board appointed members to scrutinise the account books and the content of the letter written by V G Siddhartha before his death has concluded.  The report submitted to the board of the company and a synopsis disclosure to the stock exchanges point the finger at one of the private companies of the late founder owing Rs 3,535 crores to the CDEL group as of July 2019.